EcoR1 Capital’s Forte Biosciences FBRX Stock Holding History

EcoR1 Capital’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,006	Closed	-$18.7M	–	36
2017 Q3	$18.7M	Hold	4,006	–	–	2.49%	11
2017 Q2	$18.1M	Buy	+4,006	New	+$22.5M	3.21%	10

Other funds holding FBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EcoR1 Capital's FBRX Position: Q4 2017 in Review

EcoR1 Capital sold out of Forte Biosciences (FBRX) in Q4 2017, closing a stake of 4,006 shares — an estimated $18.7M sold.

EcoR1 Capital first reported a position in FBRX in Q2 2017 and held it in 2 quarters. The position peaked at $18.7M in Q3 2017. 57 funds tracked by Wall St. Rank hold FBRX as of Q4 2017.

EcoR1 Capital reported no remaining Forte Biosciences position as of Q4 2017 after selling out during the quarter.
EcoR1 Capital sold 4,006 Forte Biosciences shares in Q4 2017, an estimated $18.7M.
EcoR1 Capital first reported a position in Forte Biosciences in Q2 2017 and held it in 2 quarters.
EcoR1 Capital's Forte Biosciences position peaked at $18.7M in Q3 2017.
57 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2017.

Based on EcoR1 Capital's 13F filing for Q4 2017, filed 14 Feb 2018.